ACLX vs BIIB: Which Stock is Better?
Side-by-side comparison of Arcellx Inc and Biogen Inc in 2026
ACLX
Arcellx Inc
$114.33
BIIB
Biogen Inc
$184.87
Key Metrics Comparison
| Metric | ACLX | BIIB | Winner |
|---|---|---|---|
| Market Cap | $6.69B | $27.13B | BIIB |
| P/E Ratio | N/A | 21.42 | BIIB |
| EPS (TTM) | $N/A | $8.63 | BIIB |
| Revenue Growth | -0.9% | -0.1% | BIIB |
| Gross Margin | 100.0% | 78.9% | ACLX |
Analyze ACLX
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACLX or BIIB a better investment?
Comparing ACLX and BIIB: Arcellx Inc has a market cap of $6.69B while Biogen Inc has $27.13B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACLX and BIIB?
ACLX (Arcellx Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACLX or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACLX or BIIB?
BIIB has higher revenue growth at -0.1% vs -0.9% for ACLX.
Which company is more profitable: ACLX or BIIB?
Arcellx Inc (ACLX) has higher gross margins at 100.0% compared to 78.9% for BIIB.
Which is the larger company: ACLX or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $27.13B compared to $6.69B for ACLX.
Should I buy ACLX or BIIB in 2026?
Both ACLX and BIIB have investment merit. ACLX trades at $114.33 while BIIB trades at $184.87. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACLX and BIIB stock?
Key differences: Market Cap ($6.69B vs $27.13B), P/E Ratio (N/A vs 21.4x), Revenue Growth (-0.9% vs -0.1%), Gross Margin (100.0% vs 78.9%).